P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000969252.00953.ba |
| _version_ | 1797280775977041920 |
|---|---|
| author | Ying Qiu Jiafan Chen Gautam Sajeev Yao Wang Dongni Ye Mingchen Ye Jingyi Chen Allison Quintana Clare Byrne David Huggar Willem Heydendael |
| author_facet | Ying Qiu Jiafan Chen Gautam Sajeev Yao Wang Dongni Ye Mingchen Ye Jingyi Chen Allison Quintana Clare Byrne David Huggar Willem Heydendael |
| author_sort | Ying Qiu |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:46:03Z |
| format | Article |
| id | doaj.art-386cdc61125c4532b625a3b39a81dee1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:46:03Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-386cdc61125c4532b625a3b39a81dee12024-03-03T06:26:04ZengWileyHemaSphere2572-92412023-08-017e00953ba10.1097/01.HS9.0000969252.00953.ba202308003-00487P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPYYing Qiu0Jiafan Chen1Gautam Sajeev2Yao Wang3Dongni Ye4Mingchen Ye5Jingyi Chen6Allison Quintana7Clare Byrne8David Huggar9Willem Heydendael101 Bristol Myers Squibb, Lawrenceville, NJ, United States1 Bristol Myers Squibb, Lawrenceville, NJ, United States2 Analysis Group, Boston, MA, United States2 Analysis Group, Boston, MA, United States2 Analysis Group, Boston, MA, United States2 Analysis Group, Boston, MA, United States2 Analysis Group, Boston, MA, United States2 Analysis Group, Boston, MA, United States3 Asclepius Analytics, New York, NY, United States1 Bristol Myers Squibb, Lawrenceville, NJ, United States1 Bristol Myers Squibb, Lawrenceville, NJ, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000969252.00953.ba |
| spellingShingle | Ying Qiu Jiafan Chen Gautam Sajeev Yao Wang Dongni Ye Mingchen Ye Jingyi Chen Allison Quintana Clare Byrne David Huggar Willem Heydendael P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY HemaSphere |
| title | P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY |
| title_full | P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY |
| title_fullStr | P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY |
| title_full_unstemmed | P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY |
| title_short | P587: REAL-WORLD CHARACTERISTICS AND USE OF ANTIEMETIC THERAPIES AMONG PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH ORAL AZACITIDINE MAINTENANCE THERAPY |
| title_sort | p587 real world characteristics and use of antiemetic therapies among patients with acute myeloid leukemia treated with oral azacitidine maintenance therapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000969252.00953.ba |
| work_keys_str_mv | AT yingqiu p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT jiafanchen p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT gautamsajeev p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT yaowang p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT dongniye p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT mingchenye p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT jingyichen p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT allisonquintana p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT clarebyrne p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT davidhuggar p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy AT willemheydendael p587realworldcharacteristicsanduseofantiemetictherapiesamongpatientswithacutemyeloidleukemiatreatedwithoralazacitidinemaintenancetherapy |